Influenza - the Greatest Master of Metamorphosis - Constant Puzzle

• Autorzy: Lidia Brydak
• Języki publikacji: EN

Abstrakty

EN

Influenza is a disease in which the continuous evolution of the virus is essential for the occurrence in the human population with seasonal epidemic, and from time to time also pandemic. According to information from WHO, between 330 million and 1.575 billion individuals suffer from influenza and influenza - like virus every year throughout the world, with deaths of between 0.5 and 1 million individuals. The evolution of the influenza virus is most apparent in the case of surface glycoproteins of the virus, but it also relates to each of the eight viral gene segments, both type A and B. Modular construction of the genome of influenza virus is also responsible for the huge variation in both genotype and phenotype. According to the Recommendations of the Advisory Committee on Immunization Practices (ACIP) recommended vaccination should we all willing ranging from 6th month until the ripe old age and instill the highest percentage of the population in each country. Vaccinated against influenza we should due to clinical indications and epidemiological indication not only ACIP recommends vaccination against influenza but also 14 International Scientific Societies. In the last epidemic season - 2012/2013 instilled only 3.75% of the population, in spite of that in Poland for many influenza seasons in many regions local authorities allocate a certain amount of funds to offer free flu vaccination to people 50 - 65 years of age who are not once in the high-risk group.(original abstract)

Słowa kluczowe

EN

Illness; Incidence; Preventive health care

PL

Choroby; Zachorowalność; Profilaktyka zdrowotna

• Czasopismo: Journal of Health Policy and Outcomes Research
• Rocznik: 2013
• Numer: nr 2
• Strony: 4--11

Twórcy

autor

Lidia Brydak

• National Institute of Public Health-National Institute of Hygiene, Warsaw, Poland

Bibliografia

• Brydak, LB. Influenza, pandemic flu myth or a real threat? Rhythm, Warszawa 2008; 1- 492 [in Polish]
• Available from: www.who.int
• Webster RG. Origin of epidemic and pandemic influenza viruses.35th Annual Meeting of the Infectious Diseases Society of America. San Francisco 13-16 September 1997, USA
• Dan Zheng., Yinglei Yi, Ze Chen. Development of live - attenuated influenza vaccines against outbreaks of H5N1 influenza. Viruses 2012; 4: 3589-3605
• Cox NJ., Subbarao K. Influenza. Lancet 1999; 353: 1277-82
• Webster W.G., Bean WI., Gorman OT., Chamers TM., Kawaoka Y. Evolution and Ecology of Influenza A Viruses. Microbiology Reviews 1992; 56:152-179
• Xiaoman Sun., Yi Shi , Xishan Lu, Jianhua Gao, Jonghua Yan, Jianxun Qi, and George F.Gao. Bat-derived influenza hemagglutinin H17 Does bind canonical avian or human receptors and most likely uses a unique entry mechanism. Cell Reports 2013; 3: 760-778
• Qing Li, Xiaoman Sun, Zhixin Li, Yue Liu, Vavricja JCh., Kainxun Qi et al. Structural and functional characterization of neuraminidase-like molecule N10 derived from bat influenza A virus. Proc Natl Acad Sci, 2012; 109,26: 18897-18902
• Weekly Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP). 2011. Center for Disease Control and Prevention, Morbidity and Mortality Weekly Report MMWR CDC Surveillance Summarie. Atlanta, GA; 10: 815
• Brydak LB., Gall W., Semkow R. Comperative anti-influenza vaccination of some groups of the population with vaccine differing in virus purification level. Arch Immunol et Ther Exp 1987; 35: 201-206
• Brydak LB. Characteristic of influenza viruses A/H3N2/ adapted to low temperature replication. 1-135 [ in polish, National Institute of Hygiene Warszawa]
• Brydak LB. Influenza - the passion of my academic research life. Top Medical Trens. Przewodnik lekarza 2011; 1: 19-24
• Brydak LB. Commentary on the article: Participation of senior citizen of the city of Poznań in gratuitous preventive vaccination against influenza. Probl. Hig. Epidemiol; 94(4): 2-3
• Brydak LB., Białek J., Rudnicka H., Denys A., Renery H., Cox N. 1997. Seroconversion assessment in billeted Military Medical University student group after antiinfluenza subunit vaccinations in 1993/1994 in Poland. Antiinfective Drugs and Chemotherapy; 15: 13-16
• Brydak LB., Całbecka M. Immunogenicity of influenza vaccine in patients with hemato-oncological disorders. Leuk Lymphoma 1999; 32: 369-374
• Brydak LB., Frącka B., Maruszak M., Rudnicka H., Nachman SA. Influenza immunization for children with bronchopulmonary dysplasia in Poland. Pediatr Infect Dis 1997; 16: 538-539
• Brydak LB., Guzy J., Starzyk J., Machała M., Góźdź S. Humoral immune response after vaccination against influenza in patients with breast cancer. Suppor Care Cancer 2001; 9: 65-68
• Brydak LB., Hryniewicz HJ., Machała M., Horban A. Humoral response to influenza vaccination in HIV-infected patients. Clinical Drug Investigation 1999; 17: 441-449
• Brydak LB., Machała M., Bentkowski P., Warzocha K., Biliński P. Humoral response to influenza vaccination in patents with non-Hodgkin lymphoma. Vaccine 2006; 24: 6620-6623
• Brydak LB., Machała M., Łaguna P., Rokicka-Milewska R. Antibody response to hemagglutinin and neuraminidase in splenectomized patens vaccinated against influenza in Poland. Clin Infect Dis 2004; 24: 225-236
• Brydak LB., Machała M., Myśliwska J., Myśliwski A., Grzonkowski P. Immune response to influenza vaccination in an elderly population. J of Clin Immunol 2003; 23: 214-222
• Brydak LB., Rokicka-Milewska R., Jackowska T., Rudnicka H., Renery H., Cox N. Kinetics of humoral response in children with acute lymphoblastic leukemia immunized with influenza vaccine in 1993 in Poland. Leuk Lymphoma 1997; 163:169-174
• Brydak LB., Rokicka-Milewska R., Klukowska A., Rudnicka H., Renery H., Cox N. Antibody kinetics in children with hemophilia immunized with influenza vaccine in 1993 in Poland. International Journal of Pediatric Hematology/ Oncology 1998; 5: 13-19
• Brydak LB., Rokicka-Milewska R., Machała M., Jackowska T., Sikorska-Fic B. Immunogenicity of subunit trivalent influenza vaccine in children with acute lymphoblastic leukemia. Pediatr Infect Dis J 1998; 17: 125-129
• Brydak LB., Roszkowska-Blaim M., Machała M., Leszczyńska B., Sieniawska M. Antibody response to influenza immunization in two consecutive epidemic seasons in patients with renal diseases. Vaccine 2000; 18: 3280-3286
• Brydak LB., Skwarczyński T., Machała M. Antibody response to influenza vaccination in healthy adults. Viral Immunol 2004; 17: 609-615
• Ciszewski A., Bilińska ZT., Brydak LB.,. Kepka C., Kruk M., Romanowska M., Księżycka E., Przyłuski J., Piotrowski W., Maczyńska R., Rużyłło W. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease. FLUCAC study. Eur Heart J 2008; 29: 1350-80
• Jahnz-Różyk K., Brydak LB., Targowski T., Machała M., Płusa T. Effect of influenza vaccinations on immune response and serum eotaxin level in patients with allergic bronchial asthma. Mediators of Infammation 2004; 13: 195-9
• Kozioł-Montewka M., Książek A., Majdan M., Stasiewicz D., Brydak LB., Janicka L., Toś-Luty S., Sitkowska J., Skórska C., Ratoszyńska J., Przylepa E. Influence of some immune factors on the IL-6 and soluble IL-2 receptors in haemodialysed patients. Int Urol and Nephrol 1997; 29: 369-75
• Mastalerz-Migas A., Steciwko A., Brydak LB. Immune response to influenza vaccine in hemodialysis patients with chronic renal failure. Adv Exp Med Biol 2013; 756: 285-290
• Więsik-Szewczyk E., Romanowska M., Milenik P., Chwalińska-Sadowska H., Brydak LB., Olesińska M., Ząbek J. Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety. Clin Rheumatol 2010; 29: 605-13
• Wyzgał J., Brydak LB., Zygier D., Pączek L., Rowiński W., Grochowiecki T. Study on efficacy of influenza vaccination in renal allograft recipients. Transplantation Proceedings 2002; 34: 572-575
• Życińska K., Romanowska M., Nowak I., Rybicka K., Wardyn K., Brydak LB. Antibody response to inactivated subunit influenza vaccine in patients with Wegener's granulomatosis. J Physiol Pharmacol Suppl 2007; 5: 819-828

Identyfikatory

DOI

10.7365/JHPOR.2013.4.1